Large Gift Establishes Colton Center for Autoimmunity at Yale School of Medicine
Philanthropists Judith and Stewart Colton have donated a major gift to establish the Colton Center for Autoimmunity at Yale, under the direction of Joseph E. Craft, MD, Paul B. Beeson Professor of Medicine and professor of immunobiology.
How do humans survive infections? Study pinpoints the role of a key hormone
To overcome an infection, the immune system has to both kill the invading virus or bacterium, and tolerate the inflammation triggered by the infection. In a new study, Yale researchers have figured out a key component of the second infection-fighting mechanism.
Life Lessons: Healthy Hips & Knees
A panel of experts walks us through the most common knee and hip ailments and their symptoms, possible treatments and various surgical options. You’ll discover tips to help strengthen your hips and knees, and help maintain your mobility and independence for years to come.Source: CPTV
A Qualitative Exploration of Triangulated Shared Decision Making in Rheumatoid Arthritis
Treat-to-target implementation in rheumatoid arthritis (RA) requires a shared decision making (SDM) process. However, ability to pay is a major determinant of patient choice, but how this factor affects SDM is under explored.Source: A Qualitative Exploration of Triangulated Shared Decision Making in Rheumatoid Arthritis
Akiko Iwasaki honored with career award in immunology
Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology at Yale School of Medicine, has been honored for her work by the American Association of Immunologists (AAI). She is the 2018 recipient of the AAI-Thermo Fisher Meritorious Career Award. The award recognizes a mid-career scientist for outstanding research contributions to the field of immunology. The association honored Iwasaki for her pioneering work in the field of antiviral immunity. She will present her research at the AAI annual meeting on May 6 in Austin, Texas.
Yale enhances its cytometry capabilities
The methods and equipment used to probe cellular questions are rapidly advancing—including, at Yale, through the addition in 2014 of CyTOF, or Cytometry Time-Of-Flight, and this past June of the CyTOF Imaging Mass Cytometer (IMC), which greatly expands Yale's ability to examine specimens that are analyzed both for clinical diagnosis and for basic research.Source: Medicine@Yale
Spurring the body to repair itself
Carla Rothlin, Ph.D., who arrived at Yale in 2009, has been recognized for her basic science work within various autoimmune diseases, including asthma, lupus, Crohn’s disease, and colitis. In 2016, the Howard Hughes Medical Institute (HHMI), the Bill & Melinda Gates Foundation, and the Simons Foundation made Rothlin one of their inaugural group of HHMI Faculty Scholars, part of a program to support early-career scientists who pursue primarily basic research projects.Source: Medicine@Yale
Rheumatologist Deborah Desir Brings Advocacy, Fundraising to the Home Front
When former ACR President Joseph Flood, MD, tapped Deborah Dyett Desir, MD, to volunteer for an ACR committee, he might have assumed that her preference would be to serve on the Committee on Rheumatologic Care or its Insurance Subcommittee. After all, Dr. Desir is in private practice at the Arthritis and Osteoporosis Center PC in Hamden, Conn., which she founded in 1993, and those committees could have been a good fit for her. She also serves as a clinical assistant professor of medicine at Yale, is president elect of the New Haven County Medical Association and is a member of the Finance Committee for the Connecticut State Medical Society.Source: The Rheumatologist
A More Unified Yale
Drs. Craft and Desir shared updates on the collaborative initiatives taking place between Science Hill, West Campus, and at the School of Medicine, as well as their research on autoimmunity and immunotherapies, with about 50 attendees at a recent Yale event entitled “A More Unified Yale; The Paragon of Science, Health, and Technology in the University's 4th Century.”
YCCI Beginning a Second Decade of Support
Although it is hard to believe, the Yale Center for Clinical Investigation (YCCI) is now in its second decade providing training resources and support for Yale’s clinical and translational investigators. With the second renewal of the Clinical and Translational Science Award (CTSA), YCCI is well poised to continue supporting innovative science to improve the health of patients everywhere.
With the Renewal of the Yale CTSA Comes New Funding Opportunities
Yale’s status as a funded CTSA site opens several additional opportunities for external funding through National Center for Advancing Translational Sciences (NCATS). Through the NCATS’s Division of Innovation, the NIH institute and division that oversee all CTSA funding, Yale investigators can now apply for new research opportunities available only to universities with funded CTSA hubs. As part of this program, Robert Sherwin and the Yale CTSA have already been awarded three of these grants; in addition, new opportunities will continue to become available.
Rheumatology Section News - November 2017
Members of our faculty and some of our former fellows attended a special ACR event this past November in San Diego. The reception named, “A More Unified Yale: The Paragon of Science, Health, and Technology in the University’s 4th Century,” featured presentations in autoimmune diseases and their complications.
Lieping Chen, PhD, wins prestigious 2017 Warren Alpert Prize
Lieping Chen, Ph.D., co-director of the Cancer Immunology Program at Yale Cancer Center and United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology and of medicine at Yale School of Medicine, has been presented with the 2017 Warren Alpert Foundation Prize for transformative discoveries in the field of cancer immunology.